Home › Funds › Aristides Capital LLC › ETON

Aristides Capital LLC position in ETON

ETON PHARMACEUTICALS INC · Health Care

Aristides Capital LLC reported holding 86,250 shares of ETON (ETON PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$4.4M, representing 0.77% of its reported portfolio and ranking #35 among its reported holdings. Aristides Capital LLC has disclosed ETON holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)86.25K sh
Reported value held$4.44M
Portfolio Weight0.77%
First reportedQ2 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Aristides Capital LLC's ETON position evolved

Aristides Capital LLC first disclosed a stake in ETON in Q2 2024 at 200,000 shares (US$658K). The position peaked in Q2 2026 at 145,410 shares, worth US$5.3M. Across 10 filings, Aristides Capital LLC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 86,250 shares valued at US$4.4M — a reduction of -59,160 shares quarter over quarter.. Notable position changes include a 31% trim in Q2 2025 (shares rose 52% over the following quarter), a 41% trim in Q3 2026 (shares rose 24% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 200.00K $658.00K New
Q3 2024 200.00K $1.20M Hold
Q4 2024 241.59K $3.22M Add
Q1 2025 241.59K $3.14M Hold
Q2 2025 167.59K $2.39M Reduce
Q3 2025 167.59K $3.64M Hold
Q4 2025 161.44K $2.73M Reduce
Q1 2026 186.04K $4.59M Add
Q2 2026 145.41K $5.26M Reduce
Q3 2026 86.25K $4.44M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ETON and 13F data

ETON (ETON PHARMACEUTICALS INC) is a Health Care company. 69 other funds we track also report a position in ETON — the largest reported positions include EcoR1 Capital, LLC (US$127.2M), Opaleye Management Inc. (US$103.5M), Nantahala Capital Management, LLC (US$45.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ETON

All ETON fund holders →

FAQ

How long has Aristides Capital LLC held ETON?

Aristides Capital LLC has disclosed ETON holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Aristides Capital LLC's current position in ETON?

As of Q3 2026, Aristides Capital LLC holds 86.25K shares of ETON (ETON PHARMACEUTICALS INC), valued at $4.44M, representing 0.77% of its reported portfolio and ranking #35.

Has Aristides Capital LLC been buying or selling ETON?

In the latest 13F filing (Q3 2026), Aristides Capital LLC reduced its position in ETON. The position peaked in Q2 2026 at 145.41K shares.

Which other funds hold ETON?

Other major institutional holders of ETON include EcoR1 Capital, LLC, Opaleye Management Inc., Nantahala Capital Management, LLC, among 69 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.